A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.
第一作者:
A J,Armstrong
第一单位:
Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.;Division of Urology, Department of Surgery, Duke University, Durham, NC, USA.;Duke Cancer Institute, Duke University, Durham, NC, USA.
作者:
医学主题词
成年人(Adult);老年人(Aged);无病生存(Disease-Free Survival);人类(Humans);吲哚类(Indoles);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);泼尼松(Prednisone);前列腺特异抗原(Prostate-Specific Antigen);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);吡咯类(Pyrroles);生活质量(Quality of Life);挽救疗法(Salvage Therapy);紫杉烷类(Taxoids)
DOI
10.1038/pcan.2015.59
PMID
26754260
发布时间
2026-03-07
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



